Lexicon Pharmaceuticals (NASDAQ:LXRX) Now Covered by StockNews.com
StockNews.com started coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research note published on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. Other analysts have also recently issued research reports about the stock. HC Wainwright reiterated a “buy” rating and issued a $4.00 price objective on shares […]
StockNews.com started coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) in a research note published on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. Other analysts have also recently issued research reports about the stock. HC Wainwright reiterated a “buy” rating and issued a $4.00 price objective on shares […]
